Evidence map›Paper›PMID 33334741›Full record

ArticleBMJ case reports2020

Treatment-induced diabetes neuropathy: description of singular clinical signs to reach a prompt diagnosis.

Pablo Guisado Vasco, Marcos Llanero-Luque, Marta Cano-Megías, María Cortés-Berdonces

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Pablo Guisado VascoInternal Medicine, Hospital universitario quironsalud Madrid, Madrid, Spain pablogvasco@gmail.com.
Marcos Llanero-LuqueNeurology, Complejo hospitalario Ruber Juan Bravo, Madrid, Spain.
Marta Cano-MegíasEndocrinology, Hospital General Universitario de Guadalajara, Guadalajara, Castilla-La Mancha, Spain.
María Cortés-BerdoncesEndocrinology, Complejo hospitalario Ruber Juan Bravo, Madrid, Spain.
Hospital Ruber Internacional · ESHospital Universitario de Guadalajara · ESHospital Universitario Quirónsalud Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 23-year-old woman diagnosed with type 1 diabetes mellitus in 2011 came to our outpatient office because of an inability to walk correctly. She was under a basal bolus insulin regimen. In the summer of 2016, she experienced a rapid improvement in her glycaemic control. A few weeks later, she started to complain of a severe burning pain in the soles of her feet (pain score 10/10). Neither macrovascular nor microvascular complications were detected. The patient was forced to walk barefoot due to an intense pain using shoes or socks and used to soak her feet in water for several hours daily. She also developed severe intolerance to environmental heat, both indoors and outdoors. A diagnosis of treatment-induced diabetic neuropathy was made. The patient was admitted to a general ward to start pain therapy. After a 6-month course of different neuropathic pain drugs, the patient was able to walk autonomously again.

Indexed as

Diabetes Mellitus, Type 1Diabetic NeuropathiesDibenzazepinesDrug Therapy, CombinationElectromyographyFemaleFootGabapentinHumansInsulinNeuralgiaTramadolTreatment OutcomeWalk TestYoung AdultDibenzazepineseslicarbazepineGabapentinInsulinTramadoldiabetesneuroendocrinologypain (neurology)

Identifiers

PMID33334741
PMCPMC7747569
OpenAlexW3112313151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.